Ignite Creation Date:
2024-05-06 @ 7:11 PM
Last Modification Date:
2024-10-26 @ 3:02 PM
Study NCT ID:
NCT05926427
Status:
RECRUITING
Last Update Posted:
2023-09-05
First Post:
2023-06-22
Brief Title:
Orelabrutinib Combined With Rituximab and Chemotherapy for RelapsedRefractory B-Cell Lymphoma Patients With Central Nervous System Involvement
Sponsor:
Organization:
Ruijin Hospital